Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · IEX Real-Time Price · USD
0.930
+0.008 (0.87%)
Jul 7, 2022 9:31 AM EDT - Market open
Balance Sheet (Annual)
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Year | 2020 | 2019 | 2018 |
---|---|---|---|
Cash & Equivalents
|
1.93 | 0.09 | 0.04 |
Short-Term Investments
|
0 | 0.1 | 0.21 |
Cash & Cash Equivalents
|
1.93 | 0.19 | 0.25 |
Cash Growth
|
909.03% | -23.06% | - |
Other Current Assets
|
0.98 | 1.62 | 1.25 |
Total Current Assets
|
2.91 | 1.81 | 1.5 |
Total Assets
|
2.91 | 1.81 | 1.5 |
Accounts Payable
|
0.56 | 0.99 | 1.18 |
Current Debt
|
0.34 | 0 | 0 |
Total Current Liabilities
|
0.9 | 0.99 | 1.18 |
Total Liabilities
|
0.9 | 0.99 | 1.18 |
Total Debt
|
0.34 | 0 | 0 |
Common Stock
|
18.85 | 12.61 | 7.69 |
Retained Earnings
|
-16.83 | -11.79 | -7.38 |
Shareholders' Equity
|
2.01 | 0.82 | 0.32 |
Total Liabilities and Equity
|
2.91 | 1.81 | 1.5 |
Net Cash / Debt
|
1.59 | 0.19 | 0.25 |
Net Cash / Debt Growth
|
733.66% | -23.06% | - |
Net Cash Per Share
|
0.02 | 0.00 | 0.00 |
Working Capital
|
2.01 | 0.82 | 0.32 |
Book Value Per Share
|
0.03 | 0.01 | 0.01 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).